Quest Diagnostics DGX
NYSE DGX
$247.35 +0.27 (+0.11%)
As of: Sep 17, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) Operating Income Growth (3y) (2012 - 2026)

Analysis

Quest Diagnostics (DGX) Operating Income Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 12.32%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 9.67%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 19.25%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn -2.58%
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn -18.92%
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 20.22%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 30.91%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 48.74%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.67%
Mar 31, 2026 9.37%
Dec 31, 2025 41.93%
Sep 30, 2025 -0.51%
Jun 30, 2025 4.12%
Mar 31, 2025 -12.30%
Dec 31, 2024 -12.34%
Sep 30, 2024 -20.31%
Jun 30, 2024 -12.67%
Mar 31, 2024 -23.11%
Dec 31, 2023 -30.49%
Sep 30, 2023 -21.90%
Jun 30, 2023 7.13%
Mar 31, 2023 20.34%
Dec 31, 2022 -28.09%
Sep 30, 2022 7.79%
Jun 30, 2022 8.12%
Mar 31, 2022 27.42%
Dec 31, 2021 34.56%
Sep 30, 2021 28.96%